270 related articles for article (PubMed ID: 29385753)
1. A Mouse Model of Enterovirus D68 Infection for Assessment of the Efficacy of Inactivated Vaccine.
Zhang C; Zhang X; Dai W; Liu Q; Xiong P; Wang S; Geng L; Gong S; Huang Z
Viruses; 2018 Jan; 10(2):. PubMed ID: 29385753
[TBL] [Abstract][Full Text] [Related]
2. A neonatal mouse model of Enterovirus D68 infection induces both interstitial pneumonia and acute flaccid myelitis.
Sun S; Bian L; Gao F; Du R; Hu Y; Fu Y; Su Y; Wu X; Mao Q; Liang Z
Antiviral Res; 2019 Jan; 161():108-115. PubMed ID: 30503887
[TBL] [Abstract][Full Text] [Related]
3. A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy.
Zhang Z; Dong Z; Wei Q; Carr MJ; Li J; Ding S; Tong Y; Li D; Shi W
J Virol; 2017 May; 91(9):. PubMed ID: 28250116
[TBL] [Abstract][Full Text] [Related]
4. A virus-like particle vaccine confers protection against enterovirus D68 lethal challenge in mice.
Dai W; Zhang C; Zhang X; Xiong P; Liu Q; Gong S; Geng L; Zhou D; Huang Z
Vaccine; 2018 Jan; 36(5):653-659. PubMed ID: 29295756
[TBL] [Abstract][Full Text] [Related]
5. Establishment of an animal challenge model as a potency assay for an inactivated Enterovirus Type 71 vaccine.
Wang KT; Lin SJ; Wang HC; Chen PC; Lin JJ; Chiang JR; Chang CL; Shih DY; Lo CF; Wang DY
Biologicals; 2016 Jul; 44(4):183-190. PubMed ID: 27068365
[TBL] [Abstract][Full Text] [Related]
6. Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection.
Zhang Z; Dong Z; Li J; Carr MJ; Zhuang D; Wang J; Zhang Y; Ding S; Tong Y; Li D; Shi W
J Virol; 2017 Jul; 91(13):. PubMed ID: 28424287
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of enterovirus‑71 (EV71) virus‑like particle vaccine against lethal EV71 infection in a neonatal mouse model.
Cao L; Mao F; Pang Z; Yi Y; Qiu F; Tian R; Meng Q; Jia Z; Bi S
Mol Med Rep; 2015 Aug; 12(2):2473-80. PubMed ID: 25936344
[TBL] [Abstract][Full Text] [Related]
8. Single B cells reveal the antibody responses of rhesus macaques immunized with an inactivated enterovirus D68 vaccine.
Zheng H; Yang Z; Li B; Li H; Guo L; Song J; Hou D; Li N; Yang J; Wu Q; Sun M; Liu L
Arch Virol; 2020 Aug; 165(8):1777-1789. PubMed ID: 32462286
[TBL] [Abstract][Full Text] [Related]
9. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus.
Wu CN; Lin YC; Fann C; Liao NS; Shih SR; Ho MS
Vaccine; 2001 Dec; 20(5-6):895-904. PubMed ID: 11738755
[TBL] [Abstract][Full Text] [Related]
10. Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection.
Cai Y; Liu Q; Huang X; Li D; Ku Z; Zhang Y; Huang Z
Vaccine; 2013 Apr; 31(18):2215-21. PubMed ID: 23499596
[TBL] [Abstract][Full Text] [Related]
11. [Immunoprotective effect of inactivated coxsackievirus A16 vaccine in mice].
Chen XP; Tan XJ; Zhang Y; Xu WB
Bing Du Xue Bao; 2014 May; 30(3):226-32. PubMed ID: 25118375
[TBL] [Abstract][Full Text] [Related]
12. Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge.
Shen C; Liu Q; Zhou Y; Ku Z; Wang L; Lan K; Ye X; Huang Z
Vaccine; 2016 Sep; 34(41):5005-5012. PubMed ID: 27562093
[TBL] [Abstract][Full Text] [Related]
13. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z
Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363
[TBL] [Abstract][Full Text] [Related]
14. Enterovirus D68 virus-like particles expressed in Pichia pastoris potently induce neutralizing antibody responses and confer protection against lethal viral infection in mice.
Zhang C; Zhang X; Zhang W; Dai W; Xie J; Ye L; Wang H; Chen H; Liu Q; Gong S; Geng L; Huang Z
Emerg Microbes Infect; 2018 Jan; 7(1):3. PubMed ID: 29323105
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice.
Mao Q; Dong C; Li X; Gao Q; Guo Z; Yao X; Wang Y; Gao F; Li F; Xu M; Yin W; Li Q; Shen X; Liang Z; Wang J
PLoS One; 2012; 7(9):e46043. PubMed ID: 23029378
[TBL] [Abstract][Full Text] [Related]
16. Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice.
Zhang Z; Dong Z; Wang Q; Carr MJ; Li J; Liu T; Li D; Shi W
Vaccine; 2018 Nov; 36(46):7095-7104. PubMed ID: 30316529
[TBL] [Abstract][Full Text] [Related]
17. A neonatal murine model of coxsackievirus A4 infection for evaluation of vaccines and antiviral drugs.
Zhang Z; Zhang X; Carr MJ; Zhou H; Li J; Liu S; Liu T; Xing W; Shi W
Emerg Microbes Infect; 2019; 8(1):1445-1455. PubMed ID: 31595827
[TBL] [Abstract][Full Text] [Related]
18. Caspase-3 inhibitor inhibits enterovirus D68 production.
Huo W; Yu J; Liu C; Wu T; Wang Y; Meng X; Song F; Zhang S; Su Y; Liu Y; Liu J; Yu X; Hua S
J Microbiol; 2020 Sep; 58(9):812-820. PubMed ID: 32870487
[TBL] [Abstract][Full Text] [Related]
19. Evaluating Treatment Efficacy in a Mouse Model of Enterovirus D68-Associated Paralytic Myelitis.
Hixon AM; Clarke P; Tyler KL
J Infect Dis; 2017 Dec; 216(10):1245-1253. PubMed ID: 28968718
[TBL] [Abstract][Full Text] [Related]
20. Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice.
Chang J; Li J; Liu X; Liu G; Yang J; Wei W; Zhang W; Yu XF
BMC Microbiol; 2015 Jul; 15():139. PubMed ID: 26169371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
